Showing results (61-70 of 188) with videos related to
Sort By:
Pageof 19
Statistical Applications in Genetics and Molecular Biology|August 5, 2008
A comparison of normalization techniques for microRNA microarray dataYoulan Rao, Yoonkyung Lee, David Jarjoura, et al.Genomics|October 1, 1992
Physical mapping of the albino-deletion complex in the mouse to localize alf/hsdr-1, a locus required for neonatal survivalG Kelsey, A Schedl, S Ruppert, et al.The Journal of Biological Chemistry|October 15, 1993
Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1AL L Shelly, K J Lei, C J Pan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2019
Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemiaA S Ruppert, J Yin, M Davidian, et al.3D Printing and Additive Manufacturing|September 8, 2018
Osseointegration of Coarse and Fine Textured Implants Manufactured by Electron Beam Melting and Direct Metal Laser SinteringDavid S Ruppert, Ola L A Harrysson, Denis J Marcellin-Little, et al.Journal of Colloid and Interface Science|October 30, 2003
Adsorption kinetics of surfactant mixtures from micellar solutions as studied by maximum bubble pressure techniqueCh Frese, S Ruppert, M Sugár, et al.Journal of Patient-Reported Outcomes|June 22, 2026
Psychometric analysis of new lymphoma-specific patient-reported symptom measures derived from the EORTC item libraryAngély Loubert, Kristin Creel, Naleen Raj Bhandari, et al.Journal of Musculoskeletal & Neuronal Interactions|December 5, 2018
Bone changes after short-term whole body vibration are confined to cancellous boneWilliam O Runge, David S Ruppert, Denis J Marcellin-Little, et al.Cancer Chemotherapy and Pharmacology|September 30, 2015
Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid tumors and adenocarcinoma of unknown primarySameh Mikhail, Maryam B Lustberg, Amy S Ruppert, et al.American Journal of Hematology|July 9, 2016
A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemiaIan W Flinn, Amy S Ruppert, William Harwin, et al.Pageof 19